Kang C - Search Results

1

Identification by shape-based virtual screening and evaluation of new tyrosinase inhibitors.

Li Q, Yang H, Mo J, Chen Y, Wu Y, Kang C, Sun Y, Sun H. Li Q, et al. Among authors: kang c. PeerJ. 2018 Jan 26;6:e4206. doi: 10.7717/peerj.4206. eCollection 2018. PeerJ. 2018. PMID: 29383286 Free PMC article.

2

Identification of 4-aminoquinoline core for the design of new cholinesterase inhibitors.

Chen Y, Bian Y, Sun Y, Kang C, Yu S, Fu T, Li W, Pei Y, Sun H. Chen Y, et al. Among authors: kang c. PeerJ. 2016 Jul 7;4:e2140. doi: 10.7717/peerj.2140. eCollection 2016. PeerJ. 2016. PMID: 27441112 Free PMC article.

3

Discovery of novel inhibitors disrupting HIF-1α/von Hippel-Lindau interaction through shape-based screening and cascade docking.

Xue X, Zhao NY, Yu HT, Sun Y, Kang C, Huang QB, Sun HP, Wang XL, Li NG. Xue X, et al. Among authors: kang c. PeerJ. 2016 Dec 15;4:e2757. doi: 10.7717/peerj.2757. eCollection 2016. PeerJ. 2016. PMID: 27994971 Free PMC article.

4

RGD Peptide-Based Target Drug Delivery of Doxorubicin Nanomedicine.

Sun Y, Kang C, Liu F, Zhou Y, Luo L, Qiao H. Sun Y, et al. Among authors: kang c. Drug Dev Res. 2017 Sep;78(6):283-291. doi: 10.1002/ddr.21399. Epub 2017 Aug 16. Drug Dev Res. 2017. PMID: 28815721 Review.

5

Amphiphilic dendritic nanomicelle-mediated co-delivery of 5-fluorouracil and doxorubicin for enhanced therapeutic efficacy.

Han R, Sun Y, Kang C, Sun H, Wei W. Han R, et al. Among authors: kang c. J Drug Target. 2017 Feb;25(2):140-148. doi: 10.1080/1061186X.2016.1207649. Epub 2016 Jul 12. J Drug Target. 2017. PMID: 27356094

6

Crocetin Inhibits Lipopolysaccharide-Induced Inflammatory Response in Human Umbilical Vein Endothelial Cells.

Song L, Kang C, Sun Y, Huang W, Liu W, Qian Z. Song L, et al. Among authors: kang c. Cell Physiol Biochem. 2016;40(3-4):443-452. doi: 10.1159/000452559. Epub 2016 Nov 25. Cell Physiol Biochem. 2016. PMID: 27889767 Free article.

7

Redox-triggered mitoxantrone prodrug micelles for overcoming multidrug-resistant breast cancer.

Qiao H, Zhu Z, Fang D, Sun Y, Kang C, Di L, Zhang L, Gao Y. Qiao H, et al. Among authors: kang c. J Drug Target. 2018 Jan;26(1):75-85. doi: 10.1080/1061186X.2017.1339195. Epub 2017 Jun 18. J Drug Target. 2018. PMID: 28583001

8

Delivery of Antipsychotics with Nanoparticles.

Sun Y, Kang C, Liu F, Song L. Sun Y, et al. Among authors: kang c. Drug Dev Res. 2016 Nov;77(7):393-399. doi: 10.1002/ddr.21331. Epub 2016 Aug 22. Drug Dev Res. 2016. PMID: 27546713 Review.

9

Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease.

Qiao H, Fang D, Chen J, Sun Y, Kang C, Di L, Li J, Chen Z, Chen J, Gao Y. Qiao H, et al. Among authors: kang c. Drug Deliv. 2017 Nov;24(1):233-242. doi: 10.1080/10717544.2016.1245367. Drug Deliv. 2017. PMID: 28156160 Free PMC article.

10

Delivery of Nanoparticles for Treatment of Brain Tumor.

Kang C, Sun Y, Zhu J, Li W, Zhang A, Kuang T, Xie J, Yang Z. Kang C, et al. Curr Drug Metab. 2016;17(8):745-754. doi: 10.2174/1389200217666160728152939. Curr Drug Metab. 2016. PMID: 27469219 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,550 results

Search Page

Filters